Cargando…

In‐solution antibody harvesting with a plant‐produced hydrophobin–Protein A fusion

Purification is a bottleneck and a major cost factor in the production of antibodies. We set out to engineer a bifunctional fusion protein from two building blocks, Protein A and a hydrophobin, aiming at low‐cost and scalable antibody capturing in solutions. Immunoglobulin‐binding Protein A is widel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurppa, Katri, Reuter, Lauri J., Ritala, Anneli, Linder, Markus B., Joensuu, Jussi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787837/
https://www.ncbi.nlm.nih.gov/pubmed/28640955
http://dx.doi.org/10.1111/pbi.12780
_version_ 1783296006021971968
author Kurppa, Katri
Reuter, Lauri J.
Ritala, Anneli
Linder, Markus B.
Joensuu, Jussi J.
author_facet Kurppa, Katri
Reuter, Lauri J.
Ritala, Anneli
Linder, Markus B.
Joensuu, Jussi J.
author_sort Kurppa, Katri
collection PubMed
description Purification is a bottleneck and a major cost factor in the production of antibodies. We set out to engineer a bifunctional fusion protein from two building blocks, Protein A and a hydrophobin, aiming at low‐cost and scalable antibody capturing in solutions. Immunoglobulin‐binding Protein A is widely used in affinity‐based purification. The hydrophobin fusion tag, on the other hand, has been shown to enable purification by two‐phase separation. Protein A was fused to two different hydrophobin tags, HFBI or II, and expressed transiently in Nicotiana benthamiana. The hydrophobins enhanced accumulation up to 35‐fold, yielding up to 25% of total soluble protein. Both fused and nonfused Protein A accumulated in protein bodies. Hence, the increased yield could not be attributed to HFB‐induced protein body formation. We also demonstrated production of HFBI–Protein A fusion protein in tobacco BY‐2 suspension cells in 30 l scale, with a yield of 35 mg/l. Efficient partitioning to the surfactant phase confirmed that the fusion proteins retained the amphipathic properties of the hydrophobin block. The reversible antibody‐binding capacity of the Protein A block was similar to the nonfused Protein A. The best‐performing fusion protein was tested in capturing antibodies from hybridoma culture supernatant with two‐phase separation. The fusion protein was able to carry target antibodies to the surfactant phase and subsequently release them back to the aqueous phase after a change in pH. This report demonstrates the potential of hydrophobin fusion proteins for novel applications, such as harvesting antibodies in solutions.
format Online
Article
Text
id pubmed-5787837
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57878372018-02-05 In‐solution antibody harvesting with a plant‐produced hydrophobin–Protein A fusion Kurppa, Katri Reuter, Lauri J. Ritala, Anneli Linder, Markus B. Joensuu, Jussi J. Plant Biotechnol J Research Articles Purification is a bottleneck and a major cost factor in the production of antibodies. We set out to engineer a bifunctional fusion protein from two building blocks, Protein A and a hydrophobin, aiming at low‐cost and scalable antibody capturing in solutions. Immunoglobulin‐binding Protein A is widely used in affinity‐based purification. The hydrophobin fusion tag, on the other hand, has been shown to enable purification by two‐phase separation. Protein A was fused to two different hydrophobin tags, HFBI or II, and expressed transiently in Nicotiana benthamiana. The hydrophobins enhanced accumulation up to 35‐fold, yielding up to 25% of total soluble protein. Both fused and nonfused Protein A accumulated in protein bodies. Hence, the increased yield could not be attributed to HFB‐induced protein body formation. We also demonstrated production of HFBI–Protein A fusion protein in tobacco BY‐2 suspension cells in 30 l scale, with a yield of 35 mg/l. Efficient partitioning to the surfactant phase confirmed that the fusion proteins retained the amphipathic properties of the hydrophobin block. The reversible antibody‐binding capacity of the Protein A block was similar to the nonfused Protein A. The best‐performing fusion protein was tested in capturing antibodies from hybridoma culture supernatant with two‐phase separation. The fusion protein was able to carry target antibodies to the surfactant phase and subsequently release them back to the aqueous phase after a change in pH. This report demonstrates the potential of hydrophobin fusion proteins for novel applications, such as harvesting antibodies in solutions. John Wiley and Sons Inc. 2017-08-01 2018-02 /pmc/articles/PMC5787837/ /pubmed/28640955 http://dx.doi.org/10.1111/pbi.12780 Text en © 2017 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Kurppa, Katri
Reuter, Lauri J.
Ritala, Anneli
Linder, Markus B.
Joensuu, Jussi J.
In‐solution antibody harvesting with a plant‐produced hydrophobin–Protein A fusion
title In‐solution antibody harvesting with a plant‐produced hydrophobin–Protein A fusion
title_full In‐solution antibody harvesting with a plant‐produced hydrophobin–Protein A fusion
title_fullStr In‐solution antibody harvesting with a plant‐produced hydrophobin–Protein A fusion
title_full_unstemmed In‐solution antibody harvesting with a plant‐produced hydrophobin–Protein A fusion
title_short In‐solution antibody harvesting with a plant‐produced hydrophobin–Protein A fusion
title_sort in‐solution antibody harvesting with a plant‐produced hydrophobin–protein a fusion
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787837/
https://www.ncbi.nlm.nih.gov/pubmed/28640955
http://dx.doi.org/10.1111/pbi.12780
work_keys_str_mv AT kurppakatri insolutionantibodyharvestingwithaplantproducedhydrophobinproteinafusion
AT reuterlaurij insolutionantibodyharvestingwithaplantproducedhydrophobinproteinafusion
AT ritalaanneli insolutionantibodyharvestingwithaplantproducedhydrophobinproteinafusion
AT lindermarkusb insolutionantibodyharvestingwithaplantproducedhydrophobinproteinafusion
AT joensuujussij insolutionantibodyharvestingwithaplantproducedhydrophobinproteinafusion